No Moonshots With Paper Planes: Alzheimer ’s Trials Need Neurotech

Most Alzheimer's drug trials are using paper measurement tools developed in the 1980's and 1990's. Neurotechnology can do better for patients, while saving us billions.

Source: Forbes.com Healthcare News - January 30, 2024 Category: Pharmaceuticals Authors: Naveen Rao, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news